Clinical Trials Directory

Trials / Completed

CompletedNCT01474603

Impact of n-3 Polyunsaturated Fatty Acids in a Protein-enriched Diet With Low GI in Type 2 Diabetes Patients

IMpact of n-3 Polyunsaturated Fatty Acids With a Protein-Enriched DiEt With Low Glycemic Index on Metabolic and Inflammatory Parameters in Type 2 Diabetic and Obese Patients: an Observational Pilot Study

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Type 2 diabetes is tightly associated with overweight and obesity. Inflammatory processes are crucial triggers for insulin resistance that paves the way to type 2 diabetes. In a previous study the investigators have shown that n-3 polyunsaturated fatty acids diminish adipose tissue inflammation in morbidly obese non-diabetic subjects. in this observational study the investigators will apply n-3 polyunsaturated fatty acids as addition to a protein-enriched diet with low glycemic index to overweight and obese patients with insulin resistance, prediabetes and manifest type 2 diabetes over up to 6 months. Primary efficacy parameters are changes from baseline in HbA1c and body weight for for type 2 diabetes and all other patients, respectively.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTn-3 PUFA in protein-enriched low-GI diet3 g per day n-3 polyunsaturated fatty acids in a protein-enriched low-GI diet

Timeline

Start date
2011-11-01
Primary completion
2014-11-01
Completion
2015-03-01
First posted
2011-11-18
Last updated
2016-03-16

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01474603. Inclusion in this directory is not an endorsement.